» Articles » PMID: 10688834

Inhibition of Degranulation and Interleukin-6 Production in Mast Cells Derived from Mice Deficient in Protein Kinase Cbeta

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2000 Feb 26
PMID 10688834
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The antigen-mediated activation of mast cells by means of IgE antibodies bound to the cell surface leads to direct interactions between FcepsilonRI receptor cytoplasmic domains and various intracellular proteins. These interactions initiate diverse signal-transduction pathways, and the activation of these pathways results in the immediate release of proinflammatory agents. A delayed response also occurs and includes the release of various cytokines. It is clear that the activation of kinases is a requirement for the exocytosis observed in mast cells. In addition to the tyrosine phosphorylation of the affected system by soluble tyrosine kinases, activity of protein kinase C (PKC) results in serine or threonine phosphorylation of multiple protein substrates. In this study, we found that mast cells derived from PKCbeta-deficient mice produce less interleukin 6 in response to IgE-Ag. The inhibition of exocytosis in the PKCbeta-deficient mast cells occurred whether the stimuli were due to the aggregation of the mast cell surface FcepsilonRI or to the calcium ionophore, ionomycin. However, no significant changes were observed in the proliferative response of the mast cells to interleukin 3 (IL-3) or in their apoptotic rate after IL-3 depletion. (Blood. 2000;95:1752-1757)

Citing Articles

Stabilizing histamine release in gut mast cells mitigates peripheral and central inflammation after stroke.

Blasco Conesa M, Blixt F, Peesh P, Khan R, Korf J, Lee J J Neuroinflammation. 2023; 20(1):230.

PMID: 37805585 PMC: 10560441. DOI: 10.1186/s12974-023-02887-7.


Protein Kinase C α and β compensate for each other to promote stem cell factor-mediated KIT phosphorylation, mast cell viability and proliferation.

Teegala L, Elshoweikh Y, Gudneppanavar R, Thodeti S, Pokhrel S, Southard E FASEB J. 2022; 36(5):e22273.

PMID: 35349200 PMC: 9298465. DOI: 10.1096/fj.202101838RRR.


Imidazolidinyl urea activates mast cells via MRGPRX2 to induce non-histaminergic allergy.

Gao J, Che D, Du X, Zheng Y, Jing H, Wang N Toxicol Res (Camb). 2021; 10(3):467-475.

PMID: 34141160 PMC: 8201555. DOI: 10.1093/toxres/tfab035.


Age-dependent involvement of gut mast cells and histamine in post-stroke inflammation.

Blasco M, Chauhan A, Honarpisheh P, Ahnstedt H, dAigle J, Ganesan A J Neuroinflammation. 2020; 17(1):160.

PMID: 32429999 PMC: 7236952. DOI: 10.1186/s12974-020-01833-1.


Antimicrobial agent triclosan suppresses mast cell signaling via phospholipase D inhibition.

Shim J, Caron M, Weatherly L, Gerchman L, Sangroula S, Hattab S J Appl Toxicol. 2019; 39(12):1672-1690.

PMID: 31429102 PMC: 6861621. DOI: 10.1002/jat.3884.